These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7350204)

  • 1. Polymerized whole ragweed: A two-year follow-up of patients treated with an improved method of immunotherapy.
    Hendrix S; Zeiss CR; Levitz D; Suszko IM; Patterson R
    J Allergy Clin Immunol; 1980 Jan; 65(1):57-60. PubMed ID: 7350204
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymerized whole ragweed: Human safety and immune response.
    Kelly JF; Zeiss CR; Patterson R; Levitz D; Suszko IM
    J Allergy Clin Immunol; 1980 Jan; 65(1):50-6. PubMed ID: 6153084
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of polymerized and unpolymerized antigen E for immunotherapy of ragweed allergy.
    Metzger WJ; Patterson R; Zeiss R; Irons JS; Pruzansky JJ; Suszko IM; Levitz D
    N Engl J Med; 1976 Nov; 295(21):1160-4. PubMed ID: 824555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study.
    Gleich GJ; Zimmermann EM; Henderson LL; Yunginger JW
    J Allergy Clin Immunol; 1982 Oct; 70(4):261-71. PubMed ID: 6811645
    [No Abstract]   [Full Text] [Related]  

  • 5. Polymerized allergens.
    Patterson R; Suszko IM
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):241-6. PubMed ID: 6354090
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
    Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
    Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
    N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled studies of intranasal immunotherapy for ragweed pollenosis.
    Mathews KP; Bayne NK; Banas JM; McLean JA; Bacon J
    Int Arch Allergy Appl Immunol; 1981; 66(2):218-24. PubMed ID: 6169652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic problems before specific immunotherapy in patients with late-summer seasonal allergic rhinitis].
    Kadocsa E
    Orv Hetil; 1994 Sep; 135(36):1963-6. PubMed ID: 7936601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of immunotherapy on the pathophysiology of ragweed pollen allergy.
    Ford SA; Baroody FM; Naclerio RM
    Rhinol Suppl; 1992; 14():52-6. PubMed ID: 1389403
    [No Abstract]   [Full Text] [Related]  

  • 11. Intralymphatic allergen immunotherapy against pollen allergy: A 3-year open follow-up study of 10 patients.
    Ahlbeck L; Ahlberg E; Nyström U; Björkander J; Jenmalm MC
    Ann Allergy Asthma Immunol; 2018 Nov; 121(5):626-627. PubMed ID: 30021119
    [No Abstract]   [Full Text] [Related]  

  • 12. Sublingual immunotherapy for allergic rhinitis.
    Med Lett Drugs Ther; 2014 Jun; 56(1444):47-8. PubMed ID: 24933088
    [No Abstract]   [Full Text] [Related]  

  • 13. Rush immunotherapy in a dog with severe ragweed and grass pollen allergy.
    Patterson R; Harris KE
    Ann Allergy Asthma Immunol; 1999 Sep; 83(3):213-6. PubMed ID: 10507265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of grass-pollen immunotherapy.
    Longo G; Barbi E
    N Engl J Med; 2000 Jan; 342(1):58-9. PubMed ID: 10627214
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for allergic rhinitis.
    Adkinson NF
    N Engl J Med; 1999 Aug; 341(7):522-4. PubMed ID: 10441610
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term immunological effects of Japanese cedar pollen-based subcutaneous immunotherapy.
    Inuo C; Ando H; Tanaka K; Nakajima Y; Tsuge I; Urisu A; Kondo Y
    Allergol Int; 2018 Jul; 67(3):408-410. PubMed ID: 29198713
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring specific immunotherapy using the 3M Diagnostic Systems reagent kits].
    Szymański W; Chyrek-Borowska S
    Pneumonol Alergol Pol; 1991; 59 Suppl 1():23-30. PubMed ID: 1843805
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of pan-allergens in commercial pollen extracts for allergen immunotherapy.
    Asero R; Mistrello G; Amato S
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):180-5. PubMed ID: 27238577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.